RxDoctor Payments Data

Steven Singer, MD

Psychiatry · Madison, WINPI 1598789331

Payments from drug & device makers

$676in general payments, 2019–2025

Across 45 payments — averaging $15.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$88
  • Johnson & Johnson$80
  • Sunovion Pharmaceuticals Inc.$77
  • Teva Pharmaceuticals USA, Inc.$75
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$56
  • AbbVie$50
  • plus $251 from 9 others

What the payments were for

  • Food & beverage$676100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$676 in reported general payments places this provider in the 75th percentile of 543 psychiatry providers in Wisconsin.

See all psychiatry providers in Wisconsin

Medicare billing

Part B allowed, 2024
$45,128
Medicare patients
83
Services billed
471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tetrabenazine19$64,091
NuedextaDextromethorphan Hbr/Quinidine26$20,731
VraylarCariprazine Hcl12$18,288
RisperdalRisperidone26$15,481
Ziprasidone Hcl81$9,974
Aripiprazole147$8,931
Divalproex Sodium ErDivalproex Sodium107$8,588
Clomipramine Hcl12$8,548
Risperidone506$7,738
Gabapentin279$7,099
Lurasidone Hcl57$6,521
Adderall XrDextroamphetamine/Amphetamine11$4,824
Olanzapine201$4,264
Quetiapine Fumarate191$4,091
Duloxetine Hcl56$3,911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$50$18,28812 claims
Johnson & JohnsonRisperdal$80$15,48126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 543 psychiatry providers in Wisconsin.

Other psychiatry in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →